• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Mirum Pharmaceuticals, Inc. - common stock (NQ:MIRM)

    87.23 -0.61 (-0.69%)
    Streaming Delayed Price Updated: 1:33 PM EST, Mar 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 245,862
    Open 86.01
    Bid (Size) 87.07 (100)
    Ask (Size) 87.40 (200)
    Prev. Close 87.84
    Today's Range 85.76 - 88.86
    52wk Range 36.88 - 109.28
    Shares Outstanding 38,297,975
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Small-Cap Shudder: Russell 2000’s 1.9% Slide Signals Cracks in Economic Resilience
    NEW YORK — The euphoric "small-cap comeback" that defined the opening weeks of 2026 came to a grinding halt on Thursday. The Russell 2000 index, the primary barometer for American small-cap health,... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Energy
    News headline image
    Mirum Pharmaceuticals Provides AZURE Clinical Program Update for brelovitug in Chronic Hepatitis Delta Virus
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire

    Performance

    YTD
    +11.7%
    +11.7%
    1 Month
    -17.3%
    -17.3%
    3 Month
    +22.0%
    +22.0%
    6 Month
    +17.6%
    +17.6%
    1 Year
    +95.4%
    +95.4%

    More News

    Read More
    Mirum Pharmaceuticals (NASDAQ:MIRM) Reports Q4 2025 Revenue Beat and 2026 Outlook ↗
    Via Chartmill
    News headline image
    Mirum (MIRM) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) Embodies the Minervini Growth Momentum Strategy ↗
    Via Chartmill
    Mirum Pharmaceuticals Inc (NASDAQ:MIRM) Offers a High-Growth Momentum and Technical Breakout Setup ↗
    Via Chartmill
    News headline image
    Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2025 Results and Provides Business Update
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    ACM Research’s AI Surge Collides With Export Controls and Chip Spending Cycles ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2025 Financial Results and Host Conference Call on February 25, 2026
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® Tablet Formulation for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Is Mirum Pharmaceuticals on a Strong Path to Profitability? ↗
    Via The Motley Fool
    News headline image
    Is Mirum Pharmaceuticals About to Soar in 2026? ↗
    Via The Motley Fool
    News headline image
    Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    A New Era in Rare Hepatology: The Deep-Dive Analysis of Mirum Pharmaceuticals (MIRM)
    Via PredictStreet
    Topics Economy Initial Public Offering
    News headline image
    3 Top Growth Stocks to Buy in the First Half of 2026 ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum Director Sells $400K Amid 91% Stock Surge -- Here's What the Firm Expects for 2026 ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline Momentum
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    5 Predictions for the Stock Market in 2026 -- and Which Stocks Will Soar the Most If They're Right ↗
    Via The Motley Fool
    Topics Artificial Intelligence Economy

    Frequently Asked Questions

    Is Mirum Pharmaceuticals, Inc. - common stock publicly traded?
    Yes, Mirum Pharmaceuticals, Inc. - common stock is publicly traded.
    What exchange does Mirum Pharmaceuticals, Inc. - common stock trade on?
    Mirum Pharmaceuticals, Inc. - common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Mirum Pharmaceuticals, Inc. - common stock?
    The ticker symbol for Mirum Pharmaceuticals, Inc. - common stock is MIRM on the Nasdaq Stock Market
    What is the current price of Mirum Pharmaceuticals, Inc. - common stock?
    The current price of Mirum Pharmaceuticals, Inc. - common stock is 87.23
    When was Mirum Pharmaceuticals, Inc. - common stock last traded?
    The last trade of Mirum Pharmaceuticals, Inc. - common stock was at 03/06/26 01:33 PM ET
    What is the market capitalization of Mirum Pharmaceuticals, Inc. - common stock?
    The market capitalization of Mirum Pharmaceuticals, Inc. - common stock is 3.34B
    How many shares of Mirum Pharmaceuticals, Inc. - common stock are outstanding?
    Mirum Pharmaceuticals, Inc. - common stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.